Symbol: |
SLC6A17
|
Description: |
solute carrier family 6, member 17 [Source:HGNC Symbol;Acc:31399]
|
Location: |
Chr1:110693108-110744824[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:93
Gene |
Compound |
Gen_sig |
Exp_pattern |
SLC6A17 |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.025 |
Up |
SLC6A17 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.049 |
Up |
SLC6A17 |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.03 |
Up |
SLC6A17 |
NSC 656471 |
0.009 |
Down |
SLC6A17 |
Nitrotolazoline |
0.041 |
Up |
SLC6A17 |
NSC 662119 |
0.049 |
Up |
SLC6A17 |
NSC 670316 |
0.035 |
Up |
SLC6A17 |
NSC 671134 |
0.023 |
Up |
SLC6A17 |
NSC 671314 |
0.023 |
Down |
SLC6A17 |
NSC 672880 |
0.023 |
Up |
SLC6A17 |
SN-38 |
0.007 |
Up |
SLC6A17 |
NSC 674080 |
0.031 |
Down |
SLC6A17 |
4-(1-Acetyloxypropen-2-yl-)-2-methoxyphenylisobutyrat |
0.042 |
Up |
SLC6A17 |
NSC 675797 |
0.001 |
Up |
SLC6A17 |
2-Naphthacenecarboxamide, N-[(6,7-dihydro-7-oxo-v-triazolo[4,5-d]pyrimidin-5-ylamino)methyl]-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo- |
0.043 |
Up |
Expression pattern: Sensitivity / Resistance
Total:7 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:62
Total:5 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
SLC6A17 |
ENST00000369789 |
hsa-mir-140-5p |
Chr16:69967006-69967027[+] |
SLC6A17 |
ENST00000331565 |
hsa-mir-588 |
Chr6:126805792-126805812[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|